These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19949750)

  • 1. Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.
    Thomas M; Castignetti D
    J Microbiol Immunol Infect; 2009 Aug; 42(4):284-9. PubMed ID: 19949750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
    Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
    J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax lethal factor inhibition.
    Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
    Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
    J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
    Kim J; Park HC; Gedi V; Park HY; Roberts AG; Atkins WM; Yoon MY
    Biochem Biophys Res Commun; 2011 Jan; 404(1):517-22. PubMed ID: 21144836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational dynamics of the anthrax lethal factor catalytic center.
    Dalkas GA; Chasapis CT; Gkazonis PV; Bentrop D; Spyroulias GA
    Biochemistry; 2010 Dec; 49(51):10767-9. PubMed ID: 21121613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.
    Chiu TL; Solberg J; Patil S; Geders TW; Zhang X; Rangarajan S; Francis R; Finzel BC; Walters MA; Hook DJ; Amin EA
    J Chem Inf Model; 2009 Dec; 49(12):2726-34. PubMed ID: 19928768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
    Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
    J Med Chem; 2006 Aug; 49(17):5232-44. PubMed ID: 16913712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factor.
    Park HC; Sung SR; Lim SM; Lee JS; Kim SK; Yoon MY
    Microb Pathog; 2012 Aug; 53(2):109-12. PubMed ID: 22561400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-inhibition between furin and lethal factor inhibitors.
    Peinado JR; Kacprzak MM; Leppla SH; Lindberg I
    Biochem Biophys Res Commun; 2004 Aug; 321(3):601-5. PubMed ID: 15358148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
    Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
    Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of anthrax lethal factor: lability of hydroxamate as a chelating group.
    Li F; Chvyrkova I; Terzyan S; Wakeham N; Turner R; Ghosh AK; Zhang XC; Tang J
    Appl Microbiol Biotechnol; 2012 May; 94(4):1041-9. PubMed ID: 22270239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of high-throughput assay of lethal factor using native substrate.
    Kim J; Choi MK; Koo BS; Yoon MY
    Anal Biochem; 2005 Jun; 341(1):33-9. PubMed ID: 15866525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insilico studies on anthrax lethal factor inhibitors: pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer.
    Roy J; Kumar UC; Machiraju PK; Muttineni RK; Kumar B V S S; Gundla R; Dayam R; Sarma JA
    J Mol Graph Model; 2010 Sep; 29(2):256-65. PubMed ID: 20727800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax toxin: the long and winding road that leads to the kill.
    Abrami L; Reig N; van der Goot FG
    Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized production and purification of Bacillus anthracis lethal factor.
    Park S; Leppla SH
    Protein Expr Purif; 2000 Apr; 18(3):293-302. PubMed ID: 10733882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-proline-based peptidomimetic inhibitors of anthrax lethal factor.
    Calugi C; Trabocchi A; Lalli C; Guarna A
    Eur J Med Chem; 2012 Oct; 56():96-107. PubMed ID: 22960696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.